Vera Therapeutics, Inc.VERANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+50.9%
5Y CAGR+45.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+50.9%/yr
Annual compound
5Y CAGR
+45.8%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $315.47M | +88.7% |
| 2024 | $167.17M | +63.9% |
| 2023 | $102.01M | +11.2% |
| 2022 | $91.75M | +166.7% |
| 2021 | $34.40M | -28.0% |
| 2020 | $47.81M | +308.6% |
| 2019 | $11.70M | - |